Cart
sales@molnova.com
Sofosbuvir impurity G
CAS No. 1337482-15-1
Sofosbuvir impurity G( —— )
Catalog No. M26457 CAS No. 1337482-15-1
Sofosbuvir impurity G is both a diastereomer of Sofosbuvir and an impurity of Sofosbuvir which is an inhibitor of HCV RNA replication.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 3202 | In Stock |
|
| 5MG | 2546 | In Stock |
|
| 10MG | 3449 | In Stock |
|
| 25MG | 5121 | In Stock |
|
| 50MG | 6780 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameSofosbuvir impurity G
-
NoteResearch use only, not for human use.
-
Brief DescriptionSofosbuvir impurity G is both a diastereomer of Sofosbuvir and an impurity of Sofosbuvir which is an inhibitor of HCV RNA replication.
-
DescriptionSofosbuvir impurity G is both a diastereomer of Sofosbuvir and an impurity of Sofosbuvir which is an inhibitor of HCV RNA replication.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMicrobiology/Virology
-
TargetHCV
-
RecptorPARP1| PARP2
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1337482-15-1
-
Formula Weight529.458
-
Molecular FormulaC22H29FN3O9P
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (188.88 mM)
-
SMILESCC(C)OC(=O)[C@H](C)N[P@](=O)(O[C@@H]1[C@@H](CO)O[C@@H](n2ccc(=O)[nH]c2=O)[C@]1(C)F)Oc1ccccc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Sch?fer P, Palacin T, Sidera M, Fletcher SP. Asymmetric Suzuki-Miyaura coupling of heterocycles via Rhodium-catalysed allylic arylation of racemates. Nat Commun. 2017 Jun 13;8:15762.
molnova catalog
related products
-
BMS-961955
BMS-961955 is an potent, allosteric inhibitor of HCV NS5B polymerase with EC50 of 7.9/4.3 nM for GT 1b/1a replicon respectively.
-
Uprifosbuvir
A novel uridine nucleotide analog HCV NS5B polymerase inhibitor for treatment of HCV infection combined with Grazoprevir and Ruzasvir.
-
GSK-2485852
GSK-2485852 (GSK2485852, GSK5852)?is a highly potent, selective HCV NS5B polymerase inhibitor with IC50 of 3.0 and 1.6 nM for HCV genotypes 1a and 1b in replicon assay, respectively.
